TOTHE EDITOR—We thank Bernard and colleagues for their comments on our re- cent publication . In a recent random- ized clinical trial , Bernard et al proved that 6 weeks of antibiotic treatment for vertebral osteomyelitis (VOM) was not inferior to 12 weeks of treatment. However, in our retrospective study , a longer du- ration of antibiotic therapy (≥8 weeks) CORRESPONDENCE � CID 2016:63 (1 October) � 995 University of Ulsan College of Medicine, Seoul, lowered the recurrence rate among patients but none of the patients in Bernard et al’s Republic of Korea with methicillin-resistant Staphylococcus cohort experienced microbiological recur- aureus (MRSA) infection or undrained rence. Although the reason for this differ- References 1. Park KH, Cho OH, Lee JH, et al. Optimal duration paravertebral/psoas abscess. Some differ- ence is unclear, the higher proportion of of antibiotic therapy in patients with hematoge- ences between both studies may potentially paravertebral/psoas abscess (49%) in our nous vertebral osteomyelitis at low risk and high account for this discrepancy. study is a possible explanation. The lower risk of recurrence. Clin Infect Dis 2016;62: 1262–9. First, the proportion of MRSA among rate of abscess (19%) in the study by Ber- 2. Bernard L, Dinh
Clinical Infectious Diseases – Oxford University Press
Published: Oct 1, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera